Menu Search
Equities

Dedicare AB (publ)

DEDIs:EBT

Dedicare AB (publ)

Actions
  • Price (SEK)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Dedicare publ AB is a Sweden-based company engaged in the employee leasing services. The Company is principally engaged in a recruitment of medical doctors, nurses and other health care workers in Sweden, Norway and Finland. Among the Company’s clients, there are 18 counties and 150 communities from Sweden and Norway and private companies. In November 2010, the Company launched its first care activity by setting up a Company Dedicare Omsorg AB. It provides support and personal assistance for people with disabilities. The Company has six wholly owned subsidiaries, including Dedicare AS, Dedicare Doctor AB, Dedicare OY, Dedicare Doctor AS, Dedicare Sales AB and Dedicare Omsorg AB. On 16 April 2015, the Company acquired Dedicare Assistanse AS.

  • Revenue in SEK (TTM)1.79bn
  • Net income in SEK66.40m
  • Incorporated1995
  • Employees1.27k
  • Location
    Dedicare AB (publ)Ringvagen 100STOCKHOLM 118 60SwedenSWE
  • Phone+46 855565600
  • Fax+46 855565645
  • Websitehttps://www.dedicare.se/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.